Dr. Ramy Sedhom highlights screening and care pathways that improve outcomes and strengthen psychosocial support for patients with cancer.
Penn Medicine | Strategic Alliance Partners
Latest from Penn Medicine
Dr. Ramy Sedhom discusses how embedded psychosocial care in oncology may improve access, engagement and emotional support during cancer care.
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.
Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 non–small cell lung cancer.
Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ
There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.
Advertisement
Advertisement
Trending on CURE
1
When a Routine Cancer Screening Stops Being Routine
2
FDA Approves Ibrance Combo for Maintenance Treatment of HR-Positive, HER2-Positive Metastatic Breast Cancer
3
Of Course I Worry: Living With Uncertainty Six Years After Remission
4
FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer
5